Award
National Institute of Allergy and Infectious Diseases 5R44AI177045-03
Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
Recipient
ABVACC, INC.
Award Amount
$914,818.00
Ceiling
$914,818.00
Awarded
April 30, 2025
Identifier
5R44AI177045-03
Award for developing immunoprophylactic treatment for Marburg virus funded by NIAID with a budget of $914,818 from 2025 to 2027.
Description
This project aims to develop an immunoprophylactic for Marburg virus, involving antibody engineering, efficacy studies, and manufacturing process development. The award is funded by NIAID under the full FOA PA-22-176, with a total budget of $914,818 for the period 2025-2027.